GSK-3β inhibitor 21
GSK-3β Inhibitor21 (compound 44) is a 6.06 μM ATP-competitive inhibitor used in Alzheimer's disease research. It has been shown in experimental models to reduce tau protein phosphorylation and inhibit amyloid aggregation, supporting its investigation in both cellular and biochemical studies.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog